anne wojcicki regeneron

News

Anne Wojcicki to buy back 23andMe and its data

Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday.

CNBC on MSN · 16h

Former 23andMe CEO Anne Wojcicki wins bid for control of her former company, topping Regeneron

Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second auction.

Invezz · 12h

Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm

Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better reassurances to customers

7hon MSN

23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.

BioSpace13h

Regeneron Backs Off 23andMe, Losing Bid to Former CEO

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Anne Wojcicki to buy back 23andMe and its data

Trending now